< Back to News
Avivagen Undertakes Human Health Proof-of-Concept
Saturday, February 4, 2017
Avivagen Inc., a Canadian life sciences company commercializing products to replace the antibiotics added to livestock feeds, has announced a project to establish proof-of-concept for a first human health application of its technology. With the help of the National Research Council of Canada (NRC), the project will evaluate the efficacy of OxC-beta(TM) Technology (“OxC-beta”) in an established research model of an infectious disease of humans.Read more here.